Results 101 to 110 of about 6,336 (192)

Immunotherapy for ocular myasthenia gravis: an observational study in Japan. [PDF]

Ther Adv Neurol Disord, 2023
Narita T, Nakane S, Nagaishi A, Minami N, Niino M, Kawaguchi N, Murai H, Kira JI, Shimizu J, Iwasa K, Yoshikawa H, Hatanaka Y, Sonoo M, Shimizu Y, Matsuo H.   +14 more
europepmc   +1 more source

Late Breaking Abstracts

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Early Relapse Frequency as a Potential Predictor of Generalization in Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Terai J, Matsubayashi T, Furuki M, Obayashi M.   +3 more
europepmc   +1 more source

Ophthalmologic clinical features of ocular myasthenia gravis. [PDF]

Medicine (Baltimore), 2023
Kim DH, Roh HC, Oh SY.
europepmc   +1 more source

Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital. [PDF]

Acta Med Philipp
Labiano AT, Cruz FMO, Mesina BVQ.
europepmc   +1 more source

Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis. [PDF]

Front Neurol
Tang T, Feng Q, Cai Y, Dong Y, Chen J, Zhang R, Zhou Q.   +6 more
europepmc   +1 more source

Acute liver failure due to hepatitis A virus presented with Guillain-Barré syndrome and ocular myasthenia gravis. [PDF]

BMJ Case Rep, 2023
Ks A, Kumar V, Ms AR, Bhat NK.
europepmc   +1 more source

Risk factors for generalization of ocular myasthenia gravis. [PDF]

Indian J Ophthalmol
Djordjevic IS, Peric S, Djordjevic SA, Lavrnic D, Marasevic K, Apostolski S, Kosac A, Basta I.   +7 more
europepmc   +1 more source

Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis: A Systematic Review and Meta-analysis. [PDF]

Neurology, 2023
Fang CEH, Bokre D, Wong SH.
europepmc   +1 more source

Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. [PDF]

Biologics
Qaqish A, Al Anber A, Abdelhafez G.
europepmc   +1 more source